Skip to main content

Funding Opportunities

The CReATe Consortium in collaboration with the American Brain Foundation is currently inviting applications for the Next Generation Research Grant in ALS and Related Disorders, see below for more details. At this time there is not a pilot project funding opportunity available, but details for a previous request can be found below.

Next Generation Research Grant in ALS and Related Disorder

Opportunity Type: Education and Career Development

Goal: This award aims to support early career researchers engaged in clinical or preclinical research on ALS, PMA, PLS, FTD, HSP, and MSP.

Sponsor: CReATe Consortium and American Brain Foundation

Eligibility Criteria: Applicants must be clinician-investigators with an MD, PhD, or equivalent terminal-level clinical or research degree and have completed clinical residency or PhD on or after July 1, 2022. Applicants at accredited US and international institutions are eligible to apply, and there is no citizenship requirement.

Application Due Date: 2026-10-08

Term: Two Years

2021 Biomarker Development/Validation Program

Opportunity Type: Pilot Grants and Other Requests for Applications

Goal: Support the discovery and/or validation of biomarkers for ALS or a related disorder (including primary lateral sclerosis [PLS], hereditary spastic paraplegia [HSP], progressive muscular atrophy [PMA], multisystem proteinopathy [MSP], and frontotemporal dementia [FTD]).

Sponsor: Clinical Research in ALS and Related Disorders for Therapeutic Development (CReATe) | ALS Association

Eligibility Criteria: Any individual with the requisite scientific training, irrespective of country of residence or origin. Priority will be given to those projects that are focused on developing biomarkers of disease mechanism and that might be relevant to the development of therapies.

Application Due Date: 2021-07-30

Term: One Year